NGL Fine Chem

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE887E01022
  • NSEID: NGLFINE
  • BSEID: 524774
INR
2,216.95
37.6 (1.73%)
BSENSE

Feb 09

BSE+NSE Vol: 11.77 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
351.95
273.34
239.17
204.26
235.37
183.38
115.33
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
351.95
273.34
239.17
204.26
235.37
183.38
115.33
Raw Material Cost
180.00
131.28
119.04
89.04
123.01
79.79
50.21
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-11.32
3.60
-7.66
16.67
-13.68
-3.81
0.56
Employee Cost
48.54
41.30
33.03
26.97
25.58
20.68
18.06
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
0.00
-0.01
0.00
-0.01
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
84.30
71.15
57.07
51.12
47.24
30.50
30.67
Total Expenditure (Excl Depreciation)
301.51
247.33
201.48
183.79
182.15
127.15
99.49
Operating Profit (PBDIT) excl Other Income
50.44
26.01
37.69
20.47
53.22
56.23
15.84
Other Income
13.02
10.87
10.22
4.30
12.78
8.46
3.58
Operating Profit (PBDIT)
63.46
36.88
47.91
24.77
66.00
64.69
19.42
Interest
3.45
1.36
0.89
0.88
1.19
1.52
1.78
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
60.01
35.52
47.02
23.89
64.81
63.17
17.64
Depreciation
14.53
9.13
8.69
8.08
6.80
6.26
5.91
Profit Before Tax
45.47
26.39
38.35
15.81
58.03
56.91
11.74
Tax
10.91
6.07
9.34
4.14
15.04
14.03
3.23
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
34.56
20.31
29.01
11.68
42.99
42.88
8.51
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
34.56
20.31
29.01
11.68
42.99
42.88
8.51
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
34.56
20.31
29.01
11.68
42.99
42.88
8.51
Equity Capital
3.09
3.09
3.09
3.09
3.09
3.09
3.09
Face Value
5.0
5.0
5.0
5.0
5.0
5.0
5.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
25.4
2.07
16.24
10.5
16.1
28.67
1.82
Operating Profit Margin (Excl OI)
14.33%
9.52%
15.76%
10.02%
22.61%
30.66%
13.73%
Gross Profit Margin
17.05%
12.99%
19.66%
11.7%
27.54%
34.45%
15.3%
PAT Margin
9.82%
7.43%
12.13%
5.72%
18.26%
23.38%
7.38%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 28.76% vs 14.29% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in nine months ended Dec 2025 is 70.16% vs -29.99% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is 93.93% vs -30.99% in Dec 2024

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is 153.68% vs 52.81% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024

Compare Nine Monthly Results Of NGL Fine Chem With
Markets Mojo
Figures in Cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
351.95
0
351.95
Other Operating Income
0.00
0.00
0.00
Total Operating income
351.95
0
351.95
Raw Material Cost
180.00
0
180.00
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
-11.32
0
-11.32
Employee Cost
48.54
0
48.54
Power Cost
0.00
0
0.00
Manufacturing Expenses
-0.01
0
-0.01
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
84.30
0.00
84.30
Total Expenditure (Excl Depreciation)
301.51
0
301.51
Operating Profit (PBDIT) excl Other Income
50.44
0.00
50.44
Other Income
13.02
0
13.02
Operating Profit (PBDIT)
63.46
0
63.46
Interest
3.45
0
3.45
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
60.01
0
60.01
Depreciation
14.53
0
14.53
Profit Before Tax
45.47
0
45.47
Tax
10.91
0
10.91
Provisions and contingencies
0.00
0
0.00
Profit After Tax
34.56
0
34.56
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
34.56
0
34.56
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
34.56
0
34.56
Equity Capital
3.09
0
3.09
Face Value
5.00
0
0.00
Reserves
0.00
0
0.00
Gross Profit Margin
17.05%
0%
0.00
17.05%
PAT Margin
9.82%
0%
0.00
9.82%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 351.95 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 28.76% vs 14.29% in Dec 2024

Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 34.56 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 70.16% vs -29.99% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 50.44 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 93.93% vs -30.99% in Dec 2024

Nine Monthly - Interest
Interest 3.45 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 153.68% vs 52.81% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.33%
in Dec 2025

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024